JD Health Collaborates with Respiratory Expert Lin Jiangtao to Launch Standardized Online Clinical Pathway for COVID-19 Patients

To guide physicians in providing more precise and standardized online diagnosis and treatment services for COVID-19 patients, JD Health, in collaboration with respiratory expert Lin Jiangtao, released the “Standardized Online Diagnosis and Treatment Pathway for Individuals Infected with the Novel Coronavirus.” On December 30, 2022, Professor Lin conducted a themed training session via live stream, providing a detailed interpretation of the core principles of the diagnostic and therapeutic pathway and engaging in in-depth discussions with fellow physicians on specific implementation details. During the 90-minute training, nearly 900 doctors from across China watched online, with over 100 physicians submitting questions. Professor Lin addressed each concern and frequently asked question raised by the participants.

Currently, online medical services have become a vital channel for the general public to seek medical consultation and treatment. In recent years, the National Health Commission and other departments have issued policy regulations such as the “Detailed Rules for the Supervision of Internet-Based Diagnosis and Treatment (Trial),” raising higher requirements for the specialization and precision of online healthcare services. As the user base for online medical services expands rapidly, both policy directives and user demands are driving the industry toward a new phase characterized by greater standardization and regulated development.

JD Health, in collaboration with respiratory expert Lin Jiangtao, jointly released the "Standardized Online Diagnosis and Treatment Pathway for COVID-19 Patients." This initiative aims to help more physicians understand the standardized protocols for online diagnosis and treatment of COVID-19, thereby enhancing the safety of internet-based medical consultations. Through training, it seeks to improve the service quality of a broader range of physicians, achieving standardization and uniformity. During the live training session, Lin Jiangtao provided a detailed explanation of the six clinical classifications of COVID-19, outlined key points for patient interviews—including assessment of general condition, symptoms and their progression, and medical history—and presented specific pharmacological solutions for different populations, such as adults, children, and pregnant or postpartum women. He also offered recommendations for home care, lifestyle, and dietary management for patients.

Professor Lin Jiangtao Provides Online Explanation of the Standardized Diagnosis and Treatment Pathway for COVID-19 Patients

Lin Jiangtao is the Immediate Past President of the Respiratory Physicians Branch of the Chinese Medical Doctor Association, Chairman of the Respiratory Disease Branch of the Beijing Medical Association, Professor in the Department of Pulmonary and Critical Care Medicine at China-Japan Friendship Hospital, and a member of the Medical Assistance Expert Group under the State Council’s Joint Prevention and Control Mechanism for the COVID-19 Epidemic. He stated, “As internet-based medical services increasingly become a vital channel for the public to access health information, seek medical guidance, and schedule appointments, the importance of standardized clinical protocols has become ever more prominent. The release of the ‘Standardized Online Clinical Pathway for Individuals Infected with SARS-CoV-2’ will help frontline internet-based practitioners further standardize their consultation processes for COVID-19-related cases, provide more scientific and precise treatment recommendations, and safeguard the physical and mental well-being of a greater number of individuals infected with SARS-CoV-2.”